Moderna said the U.S. Food and Drug Administration has agreed to review its influenza vaccine, reversing an earlier decision to reject the application.

Last week, Moderna said that the initial refusal from the FDA was inconsistent with previous feedback from the agency.

The NJ DEP has received over 1,100 calls for dead wild birds. Harsh winter conditions and possible bird flu are suspected ...

By Mariam Sunny and Michael Erman Feb 18 (Reuters) - Moderna said on Wednesday the U.S. Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a ...

From a potential new flu vaccine to a groundbreaking surgical first and critical health reminders, here's today's essential health news.

The pharmaceutical giant expressed optimism that its new flu shot would be available this year, after approval concerns.

One week after saying it was refusing to review Moderna’s application for approval of a new flu vaccine, the US Food and Drug Administration's (FDA’s) Center for Biologics Evaluation and Research ...

The US Food and Drug Administration will now review Moderna’s new, messenger RNA–based flu vaccine after all, reversing course on a decision that rocked the biopharmaceutical industry last week.

The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for ...

With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.

Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the ...

Avian flu in PA ...